Franklin Resources
STOK icon

Franklin Resources’s Stoke Therapeutics STOK Stock Holding History

Franklin Resources’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.79M Buy
146,395
+3,602
+3% +$116K ﹤0.01% 1629
2026
Q1 		$4.65M Buy
142,793
+10,571
+8% +$347K ﹤0.01% 1551
2025
Q4 		$4.2M Buy
132,222
+16,389
+14% +$493K ﹤0.01% 1480
2025
Q3 		$2.72M Buy
115,833
+34,438
+42% +$590K ﹤0.01% 1668
2025
Q2 		$924K Buy
81,395
+59,081
+265% +$561K ﹤0.01% 2030
2025
Q1 		$148K Hold
22,314
– – ﹤0.01% 2759
2024
Q4 		$246K Hold
22,314
– – ﹤0.01% 2584
2024
Q3 		$285K Sell
22,314
-1,193,886
-98% -$16.9M ﹤0.01% 2510
2024
Q2 		$16.4M Buy
1,216,200
+157,900
+15% +$2.13M 0.01% 923
2024
Q1 		$14.3M Buy
+1,058,300
New +$6.41M ﹤0.01% 964
2023
Q3 		– Sell
-12,643
Closed -$134K – 2776
2023
Q2 		$134K Buy
+12,643
New +$135K ﹤0.01% 2479

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources's STOK Position: Q2 2026 in Review

Franklin Resources increased its Stoke Therapeutics (STOK) stake by 2.5% in Q2 2026, buying an estimated $116K and bringing the position to 146,395 shares worth $4.79M. The position accounts for ﹤0.01% of the portfolio, ranked #1629.

Franklin Resources first reported a position in STOK in Q2 2023 and has held it in 11 quarters since. The position peaked at $16.4M in Q2 2024. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Franklin Resources held 146,395 shares of Stoke Therapeutics worth $4.79M as of Q2 2026.
  • Franklin Resources bought 3,602 Stoke Therapeutics shares in Q2 2026, an estimated $116K.
  • Stoke Therapeutics made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #1629 holding.
  • Franklin Resources first reported a position in Stoke Therapeutics in Q2 2023 and has held it in 11 quarters since.
  • Franklin Resources's Stoke Therapeutics position peaked at $16.4M in Q2 2024.
  • 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.